Issues exercising minds at the British Association for Psychopharmacology's annual conference in Harrogate in July are familiar: metabolic problems and schizophrenia, the relationship between sleep and depression, and old versus new antipsychotics. But as research continues, some new insights and ideas emerge. Medical writer, John Donoghue, reports on some of the sessions he attended. Copyright © 2007 Wiley Interface Ltd